Cite
MLA Citation
Y. Oki et al.. “PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE..” Hematological oncology, vol. 35, n.d., pp. 249–250. http://access.bl.uk/ark:/81055/vdc_100047414930.0x000037